Journal profile · Medicine-Pathology and Forensic Medicine
Journal of the American Society of Cytopathology
ISSN 2213-2945 · eISSN 2213-2953 · Elsevier
Journal of the American Society of Cytopathology: impact factor 2.7 (journal website); hybrid open access; APC about USD 3,050; median 60 days to acceptance (97 articles, last 24 months); 176 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of the American Society of Cytopathology is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Cervical Cancer and HPV Research, Thyroid Cancer Diagnosis and Treatment and Pancreatic and Hepatic Oncology Research, together about 31% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
JASC is the official journal of the American Society of Cytopathology,and reflects the values and priorities of the society. JASC publishes regular bimonthly issues with cutting-edge original research of the highest standard. The Journal seeks to provide an exceptional forum for interaction and dissemination of original research and educational information in the field of cytopathology and other allied disciplines in medicine. The cross-disciplinary focus of the journal ensures the sharing of information with all readers involved in the practice of cytopathology and its related basic sciences, epidemiology and clinical oncologic disciplines.JASC endeavors to have a positive impact not only on all aspects of cancer diagnosis and treatment, but also on other human disease. JASC publishes original work emphasizing novel discoveries or clinicopathologic correlations in a patient-centered environment, technological advances in basic and translational research with emphasis on the development of personalized medicine, and new or improved molecular techniques and their novel application for diagnosis or monitoring of disease. Preference is also given to original work demonstrating the scholarship of education in cytopathology including new innovative tools for continuing education and training as well as designing and implementing new assessment and evaluation techniques. It duly addresses and highlights issues relating to population health and public policy topics. It is the goal of JASC to lead the discipline of cytopathology by setting professional quality standards ensuring diagnostic excellence, advocating laboratory safety and quality, and inter-professional education for pathologists, cytotechnologists and all allied health care specialties.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pathology and Forensic Medicine
Editor-in-chief Paul VanderLaanPublisher website
Editorial board by country: none in mainland China; most named United States 95, Canada 3, Australia 3, United Kingdom 2, Hong Kong, China 1 (111 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cervical Cancer and HPV ResearchMedicine15.5%
- Thyroid Cancer Diagnosis and TreatmentMedicine8.2%
- Pancreatic and Hepatic Oncology ResearchMedicine7.3%
- AI in cancer detectionComputer Science6.2%
- Lung Cancer Diagnosis and TreatmentMedicine6%
- Salivary Gland Tumors Diagnosis and TreatmentMedicine5.6%
- Head and Neck Cancer StudiesMedicine4.6%
- Lung Cancer Treatments and MutationsMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.7Publisher website ·
- CiteScore 2026-06
- 4.6LetPub ·
- CiteScore (publisher)
- 4.6Publisher website ·
- SJR 2026-06
- 0.68LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 33OpenAlex ·
- i10-index
- 230OpenAlex ·
- 2-year mean citedness
- 0.63OpenAlex ·
- Self-citation rate
- 7.4%LetPub ·
- Share of gold OA articles
- 12.5%LetPub ·
Volume
- Articles per year
- 40LetPub ·
Articles by year OpenAlex count · 3,574 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 179 | 125 | 5 |
| 2025 | 176 | 19 | 83 |
| 2024 | 192 | 23 | 259 |
| 2023 | 210 | 6 | 676 |
| 2022 | 218 | 21 | 498 |
| 2021 | 210 | 22 | 469 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
60 daysMedian, submission to acceptance · P25–P75 44 days – 83 days
- Acceptance to online
- median 6 days (97 articles)
- Submission to online
- median 66 days
- Sample
- 97 articles with submission and acceptance dates (119 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 23 daysPublisher website ·
- Submission to acceptance
- 60 daysPublisher website ·
- Acceptance to publication
- 6 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,050 / EUR 2,850 / GBP 2,440 / JPY 378,290 | — | — | |
| Publisher website | USD 3,550 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 5
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Optional
Article types accepted5, with length limits
- annual meeting abstractsSubmissions to the American Society of Cytopathology Annual Scientific Meeting abstract book must contain the following elements: Introduction; Materials and Me…Length not stated
- book reviewsBook Reviews, Current Topics, and Editorials are published by invitation only.Length not stated
- current topicsBook Reviews, Current Topics, and Editorials are published by invitation only.Length not stated
- editorialsBook Reviews, Current Topics, and Editorials are published by invitation only.Length not stated
- letters to the editorJournal of the American Society of Cytopathology encourages Letters to the Editor, which will be published at the discretion of the editor as space permits and …main text ≤ 500 words · references ≤ 5
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics in publishing Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 2213-2945
- Electronic ISSN
- 2213-2953
- Society / sponsor
- American Society of Cytopathology
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of the American Society of Cytopathology
What is the impact factor of Journal of the American Society of Cytopathology?
The journal's website gives an impact factor of 2.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.6, h-index 33.
How long does peer review take at Journal of the American Society of Cytopathology?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 60 days (interquartile range 44–83 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of the American Society of Cytopathology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 5; Reference style: AMA; First submission: Free format: the journal's layout is not required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of the American Society of Cytopathology based?
Of the 111 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (95), Canada (3) and Australia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of the American Society of Cytopathology?
According to LetPub and DOAJ records, Journal of the American Society of Cytopathology is indexed in ESCI and Scopus.
Is Journal of the American Society of Cytopathology open access, and what is the APC?
Journal of the American Society of Cytopathology is a hybrid journal. For open-access publication: APC about USD 3,050.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .